Aldose reductase inhibitors and the complications of diabetes mellitus.
作者信息
Tomlinson D R
机构信息
Department of Pharmacology, Queen Mary and Westfield College, London, UK.
出版信息
Diabet Med. 1993 Apr;10(3):214-30. doi: 10.1111/j.1464-5491.1993.tb00049.x.
Abstract
摘要
相似文献
1
Aldose reductase inhibitors and the complications of diabetes mellitus.醛糖还原酶抑制剂与糖尿病并发症
Diabet Med. 1993 Apr;10(3):214-30. doi: 10.1111/j.1464-5491.1993.tb00049.x.
2
Aldose reductase inhibitors and diabetic complications.醛糖还原酶抑制剂与糖尿病并发症
Am J Med. 1987 Aug;83(2):298-306. doi: 10.1016/0002-9343(87)90702-9.
3
Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.醛糖还原酶抑制剂：一类用于某些糖尿病并发症药物控制的潜在新型药物。
J Med Chem. 1985 Jul;28(7):841-9. doi: 10.1021/jm00145a001.
4
[Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].醛糖还原酶抑制剂的临床应用——糖尿病并发症的防治
Nihon Rinsho. 1987 Dec;45(12):3010-27.
5
Aldose reductase inhibitors and diabetic complications.醛糖还原酶抑制剂与糖尿病并发症
Pharmacol Ther. 1992;54(2):151-94. doi: 10.1016/0163-7258(92)90031-t.
6
[Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors].[多元醇在糖尿病并发症发生发展中的作用。醛糖还原酶抑制剂的价值]
Rev Med Interne. 1992 Jan-Feb;13(1):69-79. doi: 10.1016/s0248-8663(05)80015-3.
7
The pharmacology of aldose reductase inhibitors.醛糖还原酶抑制剂的药理学
Annu Rev Pharmacol Toxicol. 1985;25:691-714. doi: 10.1146/annurev.pa.25.040185.003355.
8
The pharmacology of diabetic complications.糖尿病并发症的药理学
Curr Med Chem. 2003 Aug;10(15):1317-27. doi: 10.2174/0929867033457287.
9
[Treatment of chronic complications of diabetes mellitus with aldose reductase inhibitors].[用醛糖还原酶抑制剂治疗糖尿病慢性并发症]
Rev Assoc Med Bras (1992). 1996 Apr-Jun;42(2):109-14.
10
The role of aldose reductase inhibitors in diabetic complications: recent trends.醛糖还原酶抑制剂在糖尿病并发症中的作用：近期趋势
Methods Find Exp Clin Pharmacol. 2001 Oct;23(8):465-75. doi: 10.1358/mf.2001.23.8.662134.
引用本文的文献
1
Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.醛糖还原酶在血管炎中作为脂质过氧化产物的解毒系统发挥作用。
J Clin Invest. 1999 Apr;103(7):1007-13. doi: 10.1172/JCI4711.
2
Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.糖尿病肾病。其与高血压的关系及药物干预方法。
Drugs. 1997 Aug;54(2):197-234. doi: 10.2165/00003495-199754020-00002.
3
Metabolic cataracts in newly diagnosed diabetes.新诊断糖尿病中的代谢性白内障
Arch Dis Child. 1997 Feb;76(2):118-20. doi: 10.1136/adc.76.2.118.
4
The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.醛糖还原酶抑制剂在糖尿病并发症治疗中的疗效。与强化胰岛素治疗及胰腺移植的比较。
Drugs Aging. 1995 Jan;6(1):9-28. doi: 10.2165/00002512-199506010-00002.
Zotero 插件